Devin L. Lavender, PharmD, BCPS, BCACP
Despite new recommendations and data, some populations are not prescribed DOACs for NVAF as often as they should.
James S. Kalus, PharmD, FASHP
Pharmacists can identify undiagnosed atrial fibrillation and prevent stroke. A plan for screening for atrial fibrillation.
John Fanikos, R.Ph., MBA
Take a stroll through history exploring the therapeutic options for VTE prophylaxis in medically ill patients
Jason R. Vilar, Pharm.D., BCCCP
A discussion of standard and alternative laboratory methods to measure levels of direct-acting oral anticoagulants
Zachary Stacy, Pharm.D., M.S., FCCP, BCPS
While peripheral arterial disease affects more than 8 million U.S. patients with the potential for significant cardiovascular complications and death, disease state awareness remains low.
James S. Kalus, Pharm.D., FASHP
A discussion of the complexities of re-initiating anticoagulants after a bleeding event caused by anticoagulants